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Abstract
A close interconnection between nutrient metabolism and virulence factor expression contributes to the pathophysiology
of Pseudomonas aeruginosa as a successful pathogen. P. aeruginosa fatty acid (FA) degradation is complicated with multiple
acyl-CoA synthetase homologs (FadDs) expressed in vivo in lung tissue during cystic fibrosis infections. The promoters of
two genetically linked P. aeruginosa fadD genes (fadD1 and fadD2) were mapped and northern blot analysis indicated they
could exist on two different transcripts. These FadDs contain ATP/AMP signature and FA-binding motifs highly homologous
to those of the Escherichia coli FadD. Upon introduction into an E. coli fadD
-/fadR
- double mutant, both P. aeruginosa fadDs
functionally complemented the E. coli fadD
-/fadR
- mutant, allowing degradation of different chain-length FAs. Chromosomal
mutagenesis, growth analysis, induction studies, and determination of kinetic parameters suggested that FadD1 has a
substrate preference for long-chain FAs while FadD2 prefers shorter-chain FAs. When compared to the wild type strain, the
fadD2 mutant exhibited decreased production of lipase, protease, rhamnolipid and phospholipase, and retardation of both
swimming and swarming motilities. Interestingly, fadD1 mutant showed only increased swarming motility. Growth analysis
of the fadD mutants showed noticeable deficiencies in utilizing FAs and phosphatidylcholine (major components of lung
surfactant) as the sole carbon source. This defect translated into decreased in vivo fitness of P. aeruginosa in a BALB/c mouse
lung infection model, supporting the role of lipids as a significant nutrient source for this bacterium in vivo.
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Introduction
To occupy a diverse range of ecological niches, Pseudomonas
aeruginosa must evolve and maintain a wide array of metabolic
pathways for nutrient uptake and utilization. This adaptive
flexibility allows P. aeruginosa, a ubiquitous Gram-negative
saprophyte, to occupy environmental niches in both soil and
water and to transition into a potentially pathogenic lifestyle with
humans, plants, animals, and other microbes [1–4]. This
bacterium has been responsible for a myriad of infections
including serious bacteremia and nosocomial pneumonia [5–8],
and it has been shown to be the major cause of morbidity and
mortality among cystic fibrosis (CF) patients aged 18–24 years
[9,10]. P. aeruginosa thrives both environmentally and within a
human host because of its extensive repertoire of virulence factors
(e.g., LasA/LasB and alkaline proteases, phospholipases, lipases,
exotoxin A, type III secretion exoenzymes S/T/U/Y, rhamnoli-
pid, alginate biofilm, hydrogen cyanide synthesis, and others) and
its capacity to metabolize 70–80 different organic substrates as sole
carbon sources, notably different chain-length fatty acids (FA, C4–
C18) [11]. Our previous work suggested that P. aeruginosa expresses
phospholipases and lipases in vivo that degrades phosphatidylcho-
line (PC; Fig. 1A) as a nutrient source for bacterial replication in
the lungs of CF patients [12]. In support of these results, Miller
et al. [13] have shown that P. aeruginosa utilizes type IV pili to
twitch towards phospholipids (i.e. phosphatidylethanolamine and
PC) and long-chain FA (LCFAs).
Fatty acid degradation (Fad) in the model microbe, Escherichia
coli, employs enzymes of the Fad pathway encoded by the fad-
regulon [14,15]. E. coli possesses a single FadD, a 62-kDa fatty
acyl-CoA synthetase (FACS or AMP-forming fatty acid:CoA
ligase), encoded by the fadD gene [16,17]. The FadD protein
possesses two highly conserved sequence elements corresponding
to a proposed ATP/AMP signature motif [17,18], as well as a
signature motif involved in FA substrate binding and specificity
[19] (Fig. 1C). Following FadL-mediated importation of exoge-
nous FAs through the outer membrane [20–22] and an unknown
transportation process through the inner membrane, FadD
appears to employ these two motifs to activate FAs in a two-step
process [18,19]. In the first step of activation, an acyl bond
between the a-phosphoryl group of an ATP and the carboxyl
group of a FA is formed creating a fatty acyl-adenylate
intermediate and releasing pyrophosphate. In the second step,
the release of AMP occurs concomitantly during thioester bond
PLoS ONE | www.plosone.org 1 October 2010 | Volume 5 | Issue 10 | e13557Figure 1. The proposed FA degradation pathway in P. aeruginosa based on E. coli b-oxidation. (A) Phosphatidylcholine (PC) is the major
component of lung surfactant. PC can be cleaved by P. aeruginosa phospholipase C and lipases producing free fatty acids that are degraded via the b-
oxidation pathway by this bacterium. (B) FAs are transported through the outer membrane aided by an unidentified P. aeruginosa FadL [13,67]. In E.
coli, FA may be transported through the inner membrane via an unknown mechanism coupled to a single peripheral membrane FadD protein [18].
However, P. aeruginosa contains at least two FadDs (FadD1 and FadD2). Although there are over a dozen potential FadE homologues in the P.
aeruginosa genome, the specific enzyme(s) that catalyzes this reaction has not been identified. FadB catalyzes the next two steps followed by
cleavage of the 3-keto-acyl-CoA by FadA. Two fadBA operons (fadBA1 and fadBA5) have been identified in P. aeruginosa [29,30]. (C) Alignment of the
P. aeruginosa FadD1 and FadD2 ATP/AMP-signature and FA-binding motifs with the FadD motifs of E. coli [18,19]. Abbreviation for Fad-proteins:
Pseudomonas FadD and Virulence
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coenzyme A in the second step [23]. This FadD-catalyzed reaction
produces fatty acyl-CoA, a molecule capable of degradation by the
b-oxidation cycle or exerting transcriptional control on the E. coli
fad-regulon by interacting with the FadR regulator to derepress
fad-genes [24–27]. However, it seems currently that some fad-genes
in P. aeruginosa are induced, not by fatty acyl-CoA, but by LCFAs
[24–28]. While the biochemistry and physiology of FadD have
been well characterized in E. coli, relatively little is known about
FadD(s) in P. aeruginosa. The P. aeruginosa b-oxidation cycle in Fad
has only been partially characterized with respect to FadBAs
(Fig. 1B) [29,30]. Fad enzymes, including the broad substrate
specificity of the FACS, have also been characterized in
Pseudomonas fragi [31–33]. A study on Pseudomonas putida originally
isolated and characterized one FACS with a broad substrate range
[34]. Additional work further characterized the role of this P. putida
enzyme and identified a second FACS, naming them FadD1 and
FadD2, respectively [35,36]. In this dual FadD system, it was
shown that FadD1 played a dominant role in FA metabolism while
FadD2 was activated only when FadD1 was inactivated [36].
Comparison of the significantly larger size of the Pseudomonas
genome relative to that of E. coli, such genetic redundancies are
not unexpected. However, the importance of the redundancy and
functions of these enzymes in Fad are uncertain.
Studies on other species have indicated a link between FACS,
nutrient metabolism, and the expression of virulence factors [37–
43]. In Mycobacterium tuberculosis,3 6fadD homologues were
identified [39]. A null mutation in the M. tuberculosis fadD28 gene
showed significant replication restriction in mouse lungs, as a
result of defects in cell-wall biosynthesis and the production of
complex lipids [40]. In addition, fadD33 in the M. tuberculosis
H37Ra strain was shown to play a role in supporting growth in
mouse livers [42]. Similar to these Mycobacterium studies, the use of
random transposon mutagenesis has led to the isolation of a fadD
mutant in Salmonella enterica serovar Typhimurium which was
shown to reduce the expression of hilA (a proposed transcriptional
activator of genes in the type III secretion system [38]) and
invasion genes three- to five-fold [41]. A Xanthomonas campestris fadD
homolog rpfB mutant has decreased production of protease,
endoglucanase, and polygalacturonate lyase due to the inability to
generate a diffusible extracellular factor containing a FA moiety
[37]. A Tn5 insertion in the fadD gene of Sinorhizobium meliloti
displayed an increased swarming phenotype compared to wild-
type, resulting in an observed decrease in alfalfa root nodulation
[43]. Many of these studies correlated fadD mutations with
decreased virulence, but did not confirm or elucidate its enzymatic
role in FA metabolism. We have previously shown that P. aeruginosa
expresses fadD1 and fadD2 (PA3299 and PA3300) during lung
infections in CF patients, suggesting the importance of Fad in lipid
nutrient acquisition in vivo [12]. However, the role of fadD on
virulence and growth of the bacteria in vivo has not been
characterized.
Here, we characterized the FadD1 and FadD2 (PA3299 and
PA3300) and the respective genes with relevance to their
biochemistry and the effect on P. aeruginosa pathophysiology. The
results of genetic analyses and biochemical characterization
provided insight into reasons why redundancies in fadD are
beneficial to this pathogen. Interestingly, fadD mutants displayed
alterations in swimming and swarming motility and the production
of lipases, phospholipases, rhamnolipids, and proteases. The fadD
mutants with reduced ability to grow on phosphatidylcholine as a
sole carbon source showed decreased fitness in a mouse lung
infection model. These results provide the initial characterization
of P. aeruginosa fadD genes and suggest a pathophysiological link
between Fad and virulence.
Results
Comparison of two fadDsi nP. aeruginosa
Our previous work showed that two P. aeruginosa fadDs( fadD1
and fadD2) were expressed in vivo during lung infection in CF
patients [12]. FadD1 (PA3299) and FadD2 (PA3300) are 72%
similar (54% identical) and 72% similar (53% identical) to the E.
coli FadD, respectively, while P. aeruginosa FadD1 and FadD2 are
76% similar (60% identical) to each other. In addition, fadD1 and
fadD2 are adjacent genes, separated by 234-bp and a possible Rho-
independent transcriptional terminator (Fig. 2C). Convincingly,
the ATP/AMP signature and FA-binding motifs described for the
E. coli FadD are highly conserved in both P. aeruginosa FadD1 and
FadD2 (Fig. 1C). This preliminary analysis suggests that fadD1 and
fadD2 are both involved in Fad.
To confirm that fadD1 and fadD2 are important for Fad, we
complemented the E. coli fadD
-/fadR
- strain (E2011) with these P.
aeruginosa genes. This E. coli strain contains a mutation in the fadR
gene (fadR
-), the main repressor of the fad-regulon in E. coli,
allowing the constitutive expression of other fad-genes of the
aerobic Fad-pathway [24–27]. Both fadD1 and fadD2 of P.
aeruginosa were able to functionally complement the E. coli fadD
-
mutant (Table 1). The E. coli K12 wildtype strain was able to
metabolize C12:0 to C18:1
D9 as expected, because long-chain acyl-
CoA ($C12:0) binds efficiently to FadR to induce the fad-regulon.
Complementation of strain E2011 with the E. coli fadD gene
(fadDEC) on plasmid pET15b resulted in growth similar to that of
E. coli K12 on C12:0 to C18:1
D9, as well as on C10:0 because of the
deregulated fad-regulon as previously observed [44]. Both P.
aeruginosa fadDs were able to complement the E. coli fadD
-/fadR
-
strain to a similar level as the fadDEC complement (Table 1),
suggesting that both FadD1 and FadD2 could activate LCFAs and
medium-chain FAs (MCFAs). The various complements did not
grow on short-chain FAs (SCFAs), suggesting that other E. coli
Fad-enzymes may not support growth on SCFAs [45] and not
necessarily that the Pseudomonas FadD proteins are incapable of
producing short-chain fatty acyl-CoAs. The E2011 control strains,
either with or without the pET15b empty vector, showed no
growth on any FA (Table 1).
fadD2 and fadD1 exist on two transcripts and are induced
by FA of different lengths
To gain information on the regulatory regions of the P. aeruginosa
fadDs, we mapped their transcriptional start sites to assign putative
promoter sequences, and then determined transcription levels of
each gene on various carbon sources (Figs. 2 and 3). Promoter
mapping experiments indicated that each fadD had an indepen-
dent transcriptional start site, suggesting that they were indepen-
dently transcribed; however, northern blot analyses indicated that
fadD2 and fadD1 can be co-transcribed on a single larger transcript
or as smaller independent transcripts (Fig. 3A and 3B). Both fadD2
and fadD1 can exist as two different transcripts, suggesting some
level of regulation by the predicted transcriptional terminator or
attenuator sequence within the intergenic region (Fig. 2C). From
FadA, 3-ketoacyl-CoA thiolase; FadB, enoyl-CoA hydratase and 3-hydroxyacyl-CoA dehydrogenase; FadD, acyl-CoA synthetase; FadE, acyl-CoA
dehydrogenase; FadL, outer membrane FA translocase.
doi:10.1371/journal.pone.0013557.g001
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PLoS ONE | www.plosone.org 3 October 2010 | Volume 5 | Issue 10 | e13557Figure 2. SMART mapping of the transcriptional start sites for fadD2 and fadD1. (A) One SMART product was observed after PCR
amplification of the cDNA with SMART and fadD2 primers (oligonucleotides #798 and #373). Sequencing of the single band with a nested fadD2
primer (oligonucleotide #374) displayed a reverse-complement sequence chromatogram, showing the fadD2 transcriptional start site (indicated by
+1 at the CTTCG sequence) and the underlined SMART primer sequence. (B) Likewise, the downstream fadD1 transcriptional start site was mapped (at
the G of the sequence GCCTA) by sequencing a single PCR product. (C) fadD2 and fadD1 coding sequences and the predicted 210 and 235
promoter regions are indicated (boxed). The intergenic region between fadD2 and fadD1 contains a potential transcriptional terminator or attenuator
sequence (inverted arrows). For each gene, three black arrows indicate primers 1, 2 and 3 (#372/#375, #373/376, and #374/377) used for mapping
fadD2 and fadD1. Dashed lines indicate missing protein sequences and dots indicate stop codons.
doi:10.1371/journal.pone.0013557.g002
Table 1. Complementation of the E. coli fadD mutant with P. aeruginosa fadD homologues.
Growth on different FAs and casamino acids
a
Strain Plasmid C4:0 C6:0 C8:0 C10:0 C12:0 C14:0 C16:0 C18:1
D9 CAA
K12 (wildtype) none - - - - +4 +5 +4 +5 +6
E2011 (fadD
- fadR
-) none - - - ----- +6
E2011 (fadD
- fadR
-)p E T 1 5 b -------- +6
E2011 (fadD
- fadR
-) pET15b-fadDEc ---+2 +3 +3 +4 +4 +6
E2011 (fadD
- fadR
-) pET15b-fadD1 ---+2 +4 +4 +4 +4 +6
E2011 (fadD
- fadR
-) pET15b-fadD2 ---+2 +4 +3 +4 +4 +6
a(-) denotes no growth on a patch; (+) denotes growth: (+1) is very little growth and (+6) is heavy growth after 3 days.
doi:10.1371/journal.pone.0013557.t001
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drives the expression of both genes, and the intergenic terminator
attenuates the larger fadD1 transcript. The fadD1 promoter
immediately downstream of this regulatory element was induced
by LCFA (e.g. C18:1
D9), and initiated the expression of the smaller
fadD1 transcript (Fig. 2C, 3A and 3B). Presumably, when there was
no termination of transcription from the fadD2 promoter, fadD2
and fadD1 were transcribed together on the larger transcript of the
same size observed on both blots (Fig. 3A and 3B). Based on the
determination that these fadD genes could be independently
transcribed or co-transcribed, it was necessary to determine which
chain-length FA induced fadD1 and fadD2. The observed levels of
induction showed that fadD1 was mainly induced by LCFA,
particularly C18:1
D9, while fadD2 was specifically induced by short-
to medium-chain FA (Fig. 3C and 3D). Both fadD genes showed
some level of expression under all conditions tested, indicating low
levels of constitutive expression.
fadD mutants showed reduced ability to grow on various
FAs
To further confirm the involvement of each fadD in Fad, we
generated single and double mutants for growth analysis on
various FAs as sole carbon sources (Fig. 4). As previously observed
for fadBA mutants [30], growth defects were exemplified by slower
growth and lower overall final cell densities in various FA media,
presumably, due to reduced rates of Fad and growth inhibiting
intermediates. Both fadD1 and fadD2 single mutants had various
levels of defects when grown on all FAs (Fig. 4). However, the
fadD1 mutant displayed a greater growth defect on all FAs than the
single fadD2 mutant, with the exception of C8:0 and C10:0 where
FadD2 seems to be equally as important as FadD1 (Fig. 4D and
4E). The DfadD2D1 mutant showed more dramatic growth defects
on all FAs than the individual single mutants, indicating that both
proteins were involved in the metabolism of all chain-length FAs
tested. The lack of a complete defect in Fad of this double mutant
suggests that other fadDs exist in P. aeruginosa. The complemented
single and double mutants fully restored growth on all FAs (Fig. 4),
while empty vector miniCTX2 controls did not complement
growth on the FAs (data not shown). No apparent defects were
observed for any mutant grown with casamino acids (CAA) as a
sole carbon source (Fig. 4A). Based on the physiological data (Fig. 3
and 4), fadD1 was found to be important for the metabolism of all
FAs, particularly the unsaturated LCFA oleate, while fadD2 was
also important in Fad but more so for MCFA (C8:0 and C10:0)
degradation.
Figure 3. Transcriptional profile of fadD1 and fadD2 in various FAs. For a short- (C8:0), medium- (C10:0), and long-chain FA (C18:1
D9), northern
blot analysis indicated two possible transcripts for both fadD genes when probed with either fadD1 (A) or fadD2 (B). Gene-fusion studies of strains
P518 (PfadD1-lacZ) and P520 (PfadD2-lacZ), grown to mid-log phase, showed differential expression of fadD1 and fadD2 in the presence of different FAs
(C and D). (C) fadD1 was up-regulated in the presence of the unsaturated LCFA (C18:1
D9), while fadD2 expression was significantly increased in the
presence of shorter chain FAs (C8:0,C 10:0) (D). For (C) and (D), all cultures had identical growth-rates and overall cell densities (data not shown).
doi:10.1371/journal.pone.0013557.g003
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PLoS ONE | www.plosone.org 5 October 2010 | Volume 5 | Issue 10 | e13557Kinetic properties of purified FadDs support differential
FA chain-length preferences
To determine the substrate specificities of each FadD and
further clarify the reason why P. aeruginosa possesses multiple fadD
homologues, both FadD proteins were purified to near homoge-
neity from an E. coli fadD
- strain to ensure that all acyl-CoA
synthetase activities were derived only from purified recombinant
FadD1 or FadD2 (Fig. 5A). FadD1 of P. aeruginosa coupled CoASH
to LCFA better than to SCFA or MCFA, as exemplified by larger
Vmax and lower Km values for C18:1
D9 and C16:0 than FAs of other
chain-lengths (Fig. 5B and Table 2). The reverse was true for
FadD2, where this enzyme had higher Vmax and lower Km for
SCFA and MCFA than LCFA (Fig. 5C and Table 2). The catalytic
efficiency (kcat/Km) of FadD1 was significantly higher for LCFA
(C18:1
D9,C 16:0, and C14:0) than MCFA (C12:0 to C8:0) or SCFA
(C6:0 and C4:0), while the catalytic efficiency of FadD2 was higher
for MCFA and SCFA than LCFA (Table 2). The kinetic
parameters for ATP and catalytic efficiency of both enzymes
were comparable when ATP was limited in the reaction, with
FadD1 being a slightly better catalytic enzyme for ATP than
FadD2 (Table 2). Clearly, multiple FadDs in P. aeruginosa, with
broad substrate conversion capabilities and overlapping chain-
length preferences, afford this bacterium the ability to optimally
metabolize FAs of various chain-lengths.
fadD mutants influence virulence behavior of P.
aeruginosa
Based on work in other bacteria that showed an interconnection
between fadD genes and expression of virulence factors [37–43],
we sought to determine if a similar connection existed in P.
aeruginosa. Increased swarming motility of S. meliloti, leading to
altered virulence, was previously attributed to hyperflagellation
observed by transmission electron microscopy (TEM) [43]. While
no apparent differences in structure or numbers of flagella were
observed for the fadD mutants compared to wildtype PAO1 using
TEM in the current study (data not shown), we showed that fadD
mutations could still significantly influence swarming and
swimming motility in P. aeruginosa (Fig. 6). The fadD2 mutant
was severely defective in swimming and swarming motility relative
to the wildtype PAO1 strain (Fig. 6). Although the fadD1 single
mutant showed no apparent difference in swimming motility, it
displayed increased swarming migration compared to PAO1.
Swarming was most pronounced in the DfadD2D1 mutant. In the
DfadD2D1 mutant, it was very interesting to observe that the fadD1
Figure 4. Growth analysis of fadD mutants using various FAs as sole carbon sources. Although fadD mutants showed various defects when
grown with FAs of different chain-lengths (see top of graphs in B-I), no growth defects were observed for any of the mutants when grown with
casamino acids (CAA) as a control (A). All three P. aeruginosa mutants were fully complemented by the respective missing gene(s) and grew as well as
the wildtype PAO1 on all carbon sources. Not shown are the three control mutant strains (PAO1-fadD1::FRT/attB::miniCTX2, PAO1-fadD2::FRT/
attB::miniCTX2, and PAO1-DfadD2D1::FRT/attB::miniCTX2) having the empty miniCTX2 integrated into their chromosomes, where all had similar
growth characteristics to the non-complemented mutants.
doi:10.1371/journal.pone.0013557.g004
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fadD2 mutation. Each complemented strain showed that swim-
ming and swarming motility could be restored to wildtype levels,
indicating no unforeseen secondary or polar mutations affected
these behaviors.
The production of other virulence factors was also monitored
for the fadD mutants. Interestingly, the fadD2 mutant showed
significantly decreased production of total hemolysins, proteases,
lipases, and rhamnolipids (Fig. 7). No other mutant or complement
showed noticeable decreases in the production of these virulence
factors compared to the wildtype PAO1 strain. The supression of
the fadD2 mutation by the fadD1 mutation, in the DfadD2D1
mutant, reversed the reduction in virulence factor expression seen
in the single fadD1 mutation alone (Fig. 7). Similar suppression was
observed in swimming and swarming motilities (Fig. 6). The
altered virulence behaviors and suppression were not due to
differences in growth-rates or overall final cell densities, as all
seven strains (i.e. wildtype, mutants, and complements) grew
identically in LB media prior to testing for these virulence traits
(Fig. 7E). Mechanisms governing these differences remain to be
elucidated.
Compromised ability of fadD mutants to degrade FA and
PC leads to reduced P. aeruginosa fitness in mice
Since fadD1 and fadD2 are expressed in vivo during CF lung
infections [12] and are potentially important for PC degradation
(Fig. 1A), it was necessary to determine whether these mutants are
deficient in growth on PC. Growth analysis on PC showed only
slight decreases in the maximum cell density of the individual
single fadD mutants, while the fadD2 mutant exhibited a delayed
log phase (Fig. 8A). The DfadD2D1 mutant exhibited the greatest
growth defect, while the single and double fadD complements
restored growth to wildtype levels. Since PC is the major
component (70%) of the essential lung surfactant [46] and is a
potential nutrient source in vivo [12], it was important to assess
whether the growth defects of these mutants on PC would result in
decreased fitness in vivo.
Figure 5. Purification and biochemical characterization of the two P. aeruginosa FadDs. (A) FadD1 (lane 1; MW=61,655) and FadD2 (lane 2;
MW=61,737) were purified to near homogeneity from an E. coli fadD
- strain to prevent potential contamination of E. coli FadD. FadD1 activities (B)
were higher for LCFAs (C18:1
D9.C16:0), while FadD2 (C) had higher activities for shorter chain FAs (C8:0.C10:0.C4:0.C6:0).
doi:10.1371/journal.pone.0013557.g005
Table 2. Kinetic properties of FadD1 and FadD2 with various substrates.
FadD1 Kinetic Parameter











ATP 213 0.219 10.6 20.7 182 0.187 10.9 17.2
C4:0 137 0.141 27.4 5.1 167 0.172 33.3 5.2
C6:0 133 0.137 26.7 5.1 159 0.164 31.8 5.2
C8:0 125 0.128 25.0 5.1 204 0.210 20.4 10.3
C10:0 116 0.119 23.3 5.1 182 0.187 36.4 5.1
C12:0 130 0.134 26.0 5.1 137 0.141 41.1 3.4
C14:0 130 0.134 13.0 10.3 109 0.112 43.5 2.6
C16:0 154 0.158 15.4 10.3 99 0.102 49.5 2.1
C18:1
D9 217 0.223 21.7 10.3 101 0.104 50.5 2.1
aKinetic constants (Vmax and Km) determined using Hanes-Woolf plot.
bnmole of acyl-CoA formed/min/mg of protein.
cs
-1; determined using MW of FadD1 (61,655) and FadD2 (61,373).
dmM of ATP or FA.
emM
-1 s
-1; represents enzyme catalytic efficiency.
doi:10.1371/journal.pone.0013557.t002
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complements were first tested to determine if the defect reduced
their ability to utilize various sole carbon sources. Each mutant
and complement pair was inoculated into seven growth media
with different sole carbon sources including LB, CAA, glucose,
PC, C18:1
D9,c h o l i n e ,a n dg l y c e r o l ,a n db a c t e r i a lC F Uw e r e
determined after 24–48 h growth (Fig. 8B). As, expected, all three
single or double fadD mutants were less competitive than their
corresponding complements but only in media containing PC or
C18:1
D9 as sole carbon sources. Next, to evaluate the fitness of the
fadD mutants within the lung environment, in vivo competition
between the mutants and their complements was analyzed.
Following intratrachael inoculation of equal ratios of each mutant
and its complement pair into BALB/c mice (6610
6 CFU/
animal),bacterial CFUrecovered from the lungs were determined
24 h and 48 h postinfection and the competitive index (CI) was
calculated (Fig. 8C and 8D). The CI is defined as the ratio of
mutant CFU relative to CFU of the respective complement [47].
In all of these competition experiments, with the exception of the
fadD2 mutant after 48 h, the average total CFU/mouse recovered
was greater than the initial inoculum showing that these strains
maintained the ability to replicate within the mouse lung.
Although the fadD1 single mutant showed decreased competitive
fitness within the lung compared to the complement, the CI of the
fadD1 mutant remained relatively unchanged between the two
time points analyzed. At 24 h postinfection, all of the mutants
exhibited decreased competition levels relative to their respective
complements and the fadD2 and DfadD2D1 mutant strains showed
greater reduced fitness than the fadD1 mutant. By allowing the
infections to persist for 48 h, the reduced CI of the fadD2 mutant
showed a significantly higher defect in competitive fitness. By
48 h, the CI of the DfadD2D1 mutant was half of that observed at
24 h. Clearly, the DfadD2D1 mutant with significantly reduced
ability to degrade PC (Fig. 8A), while showing no altered virulence
factor secretion (Fig. 7), had its competitive fitness reduced by
three-fold. This strongly suggests that the ability to degrade PC as
a nutrient source allows P. aeruginosa to replicate within the lung
environment.
Figure 6. Altered swimming and swarming motility of P. aeruginosa fadD mutants. (A) Swimming motility of fadD mutants and their
complements. (B) Swarming migration of fadD mutants and their complements. These figures are representative of multiple experiments. Strain
designation is the same as shown in Table 3: wildtype PAO1, P007; fadD1
-, P175; fadD2
-, P547; DfadD2D1, P177; fadD1
- complement, P541; fadD2
-
complement, P549; and DfadD2D1 complement, P543.
doi:10.1371/journal.pone.0013557.g006
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This study focused on characterizing two P. aeruginosa acyl-CoA
synthetases (FadD1 and FadD2), which are expressed during lung
infection in CF patients suggesting their importance in lipid
degradation for bacterial replication [12]. The transcriptional
profile and substrate preferences of FadD1 and FadD2 were
determined to initially shed light onto why P. aeruginosa has this
genetic redundancy. The fadD1 and fadD2 of P. aeruginosa were
differentially regulated in response to the type of available FA
(Fig. 3), suggesting that each FadD has a different FA substrate
preference. While both fadD1 and fadD2 were controlled by their
common and independent promoters, the expression of fadD1
downstream could be partially attenuated by some FAs due to a
putative intergenic Rho-independent transcriptional-terminator
(Fig. 2). Based on the growth defects, both fadD genes are
individually important for the degradation of all chain-length FAs
tested. These results are further supported by the observation that
the DfadD2D1 mutant had the greatest growth defect on all chain-
length FAs (Fig. 4). These growth defects may be due to a
bottleneck in the conversion of exogenous FA to acyl-CoA created
by the inactivation of two genes that facilitate this process. The
complementation study in E. coli was initially inconclusive with
respect to metabolism of SCFA and some MCFA substrates by P.
aeruginosa FadDs (Table 1), as other E. coli Fad-proteins (e.g. FadE,
FadA and FadB) do not allow the metabolism of shorter-chain FAs
[45]. However, the kinetic parameters, especially the catalytic
efficiencies (Table 2), provided more precise biochemical evidence
for the differences in substrate preferences. By comparing the
kinetic measurements of these enzymes, it appears that FadD1
preferred LCFA for degradation, while FadD2 was more suited to
the degradation of SCFAs and MCFAs (Fig. 5 and Table 2).
Together, the enzyme kinetics, gene-fusion, and growth analyses
data all support the importance of FadD2 for degradation of
SCFA and MCFA and FadD1 is more suited for LCFA
degradation (Fig. 3, 4 and 5). Therefore, we can conclude that
these proteins have different substrate preferences and are not
functionally equivalent.
We showed here that mutations in fadD genes, important for FA
b-oxidation in P. aeruginosa, also influenced two modes of motility
and virulence factor expression. Our fadD2 mutant had reduced
swimming and swarming motilities and decreased virulence factor
expression (proteases, phospholipases, rhamnolipids, and lipases),
while the fadD1 mutant and the DfadD2D1 double mutant only
showed an increased swarming phenotype. In the double mutant
background, the presence of the fadD1 mutation suppresses the
phenotype of the fadD2 mutation (Figs. 6 and 7). It will be
interesting to determine the exact cause of the phenotypic
suppression in future investigations. At this point, we speculate
that the reduced swarming phenotype of the fadD2 mutant is due
to decreased production of rhamnolipids (Fig. 6 and 7), as
rhamnolipids were previously shown to be necessary for P.
aeruginosa swarming motility [48]. These phenotypic differences in
virulence factor expression further support the observation that
FadD1 and FadD2 are not functionally equivalent. Although we
did not exhaust the large list of virulence determinants, nor were
able to show the exact method by which FadD2 influences their
expression, this characterization of several virulence factors links
Fad and virulence factor expression in P. aeruginosa.
Additionally, the expression of genes in vivo that encode proteins
with b-oxidative activity, along with several other PC degradation
genes, strongly support the hypothesis that lipids within the lung
may be important nutrient sources for P. aeruginosa [12] and serve
as signals to control virulence factor expression [13]. Phospholi-
pase- and lipase-derived components of PC (LCFA, glycerol, and
phosphorylcholine) could individually serve as sole carbon sources
(Fig. 1A) and provide nitrogen and phosphorous contributing to
virulence [49,50]. Of these three PC components, the two LCFAs
from each PC molecule yield the most carbon and energy.
Therefore, the determination that both FadD1 and FadD2 were
important for LCFA degradation was pivotal as PC, the major
component of lung surfactant, is primarily composed of LCFA
(C16:0, 50–60%; C14:0,C 16:1,C 18:1, and C18:2 each at 10–20%)
[46]. To that end, we analyzed the growth of these mutants on PC
as a sole carbon source. The delayed log-phase of the fadD2
mutant is likely due to the decreased expression of lipase and
phospholipase, thereby reducing the cleavage rate of exogenous
PC into its usable components and thus slowing growth. Since it
was shown that the DfadD1D2 mutant had no apparent
deficiencies in lipase or phospholipase expression, yet exhibited
the greatest decrease in growth on all FAs tested, we believe that its
reduced growth on PC is attributed to a reduced ability to degrade
FAs, as this double mutant degrades phosphorylcholine and
glycerol as well as the complement. Since the fadD mutants fully
retained the ability to degrade choline and glycerol and only had
reduced levels of FA degradation, it was not surprising that the
DfadD1D2 double mutant could still degrade PC.
Because PC is a major lung surfactant common in all mammals,
including mice [51], a mouse lung infection model [52] was
utilized to analyze the competitive growth in vivo between the P.
aeruginosa fadD mutants and their complements. Replication of the
fadD2 mutant was observed after 24 h, while all other strains
showed an increase after 48 h, indicating all strains were able to
replicate in vivo. This could be explained by the fact that our
DfadD1D2 double mutant still had significant ability to degrade PC
and its components, and that P. aeruginosa expresses genes in the
lung for both amino acid and PC degradation [12] and possibly
DNA [53]. After 24 h and 48 h, all mutants showed lower in vivo
fitness than their complements, which means that lipids are
significant nutrient sources in the mouse lung. The CIs of the
fadD2 mutant were consistently lower than those of the fadD1
mutant after both 24 h and 48 h, attributed to the fadD2 mutant’s
decreased production of virulence factors. Although the DfadD2D1
mutant only showed partial defect in PC degradation and no effect
in virulence factor expression or the ability to grow with amino
acids, this partial defect in PC degradation translated into
significantly reduced in vivo lung fitness. This is further supported
by the in vitro competition results where all single and double fadD
mutants exhibited competition defect only on PC and C18:1
D9.
Therefore, the significantly lowered CI after 48 h for the double
DfadD2D1 mutant can only be due to a reduced ability to degrade
PC as a nutrient source for replication in the mouse lung.
In this study, a pathophysiological link between the acquisition
of lipid nutrients and virulence in vivo was established by i)
characterizing these two P. aeruginosa fadD genes expressed during
lung infection in CF patients, ii) determining that there may be
some connection between fad-genes and the expression of certain
virulence traits, and iii) showing that mutations in these genes
Figure 7. Analysis of protease, hemolysin, lipase, and rhamnolipid production by P. aeruginosa fadD mutants. The fadD2 mutant
displayed significantly decreased production of proteases (A), hemolysins (B), lipases (C), and rhamnolipids (D), while no growth defects in LB were
observed (E). These assays were conducted in triplicate and are expressed as a percentage of the mean value of the wildtype PAO1 6 s.e.m.
doi:10.1371/journal.pone.0013557.g007
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lungs. These data support results from a previous in vivo gene
expression study showing that P. aeruginosa expresses glp-, bet-, and
especially, fad-genes to degrade PC as one of the nutrient sources
in the lungs [12]. We predict that P. aeruginosa mutants, completely
blocked in PC utilization, will have significantly lower in vivo
fitness, further supporting PC as a significant nutrient source for
this important pathogen in mammalian lungs.
Materials and Methods
Ethics statement
All animal experiments were conducted in compliance with the
NIH (National Institutes of Health) Guide for the Care and Use of
Laboratory Animals and were approved by the University of
Hawaii Institutional Animal Care and Use Committee (protocol
No. 06-023-04).
Bacterial strains and growth media
Strains and plasmids used in this study are shown in Tables 3
and 4. E. coli EPMax10B was routinely used as a strain for cloning
and was cultured in Luria-Bertani (LB) medium (Difco). P.
aeruginosa strain PAO1 and derivatives were cultured on Pseudo-
monas Isolation Agar or Broth (PIA or PIB; Difco) or LB medium.
PAO1-fadD1::FRT, PAO1-fadD2::FRT, PAO1-DfadD2D1::FRT,
and their complements were cultured in 1x M9 minimal medium
+1% Brij-58 (Sigma) +1% casamino acids (CAA) or 0.2% (w/v) of
the individual FA, C4:0 to C16:0,o rC 18:1
D9 (Sigma; Fig. 4), and
1x M9 minimal medium +1% Brij-58 +0.2% phosphatidyl-
choline (PC, Sigma; Fig. 8A) for growth analyses. The fusion
strains PAO1-fadD1::FRT-lacZ/attB::miniCTX2-fadD1 and PAO1-
fadD2::FRT-lacZ/attB::miniCTX2-fadD2 were cultured in 1x M9
+1% Brij-58 +1% CAA60.1% (w/v) C4:0 to C16:0,o rC 18:1
D9 for
induction studies (Fig. 3C and 3D). For in vitro competition studies
(Fig. 8B), each mutant/complement mixture of equal cell density
was grown in seven different media, including LB, 1x M9 +20 mM
glucose, 1x M9 +1% CAA, 1x M9 +1% Brij-58 +0.2% PC, 1x M9
+1% Brij-58 +0.2% C18:1
D9,1 xM 9+40 mM glycerol, and 1x M9
+30 mM choline. Stock solutions of all FAs were made as
previously described [30]. Unless indicated otherwise, all liquid
cultures were grown at 37uC with a shaking speed of
200 r.p.m.
General molecular methods
All molecular methods and their components were employed as
previously described [54]. Oligonucleotides utilized in this study
were ordered through Integrated DNA Technology (IDT,
Table 5).
Complementation of E. coli fadD mutant
The E. coli fadD
- fadR::Km
r mutant (E2011) was engineered by
transferring the fadR::Km
r mutation from JWC285 into the K27
(fadD
-) strain via P1 transduction. The resulting double mutant
strain was then used for the complementation study. To construct
the E. coli complementation vectors, coding regions of P.
aeruginosa fadD1 and fadD2 were amplified from PAO1 chromo-
somal DNA using oligos #341 +#342 and #339 + #340,
respectively. PCR products were then digested with NdeI +
BamHI and ligated individually into pET15b, digested with the
same enzymes, yielding pET15b-fadD1 and pET15b-fadD2.A sa
control for the complementation study, the E. coli fadD gene
(fadDEc) was also amplified from strain K12 chromosomal DNA
using oligos #1092 + #1093. The 1.8-kb PCR product was
digested with AseI + BamHI, and ligated with pET15b digested
with NdeI + BamHI, yielding pET15b-fadDEc.T h e s et h r e e
vectors, pET15b-fadD1,p E T 1 5 b - fadD2, and pET15b-fadDEc,
were introduced into E. coli strain E2011 for complementation.
E2011, harboring each complementation vector, was patched on
1x M9 minimal medium + 1% Brij-58 +1% CAA or 0.2% various
fatty acids, and growth was determined after 3 days incubation at
37uC( T a b l e1 ) .
Construction of PAO1 fadD mutant and
complementation strains
Three fadD mutant strains (PAO1-fadD1::FRT,P A O 1 - fadD2::FRT,
and PAO1-DfadD2D1::FRT) were engineered, respectively, using
three allelic-replacement plasmids (pEX18T-fadD1::Gm-FRT,
pEX18T-fadD2::Gm-FRT, and pEX18T-DfadD2D1::Gm-FRT)a s
previously described [55]. These gene-replacement vectors were
constructed by inserting the SmaI Gm
r-FRT cassette at the EcoRV
site to inactivate fadD1 gene, the SmaI site to inactivate fadD2 gene, or
at the deleted fadD2D1 SmaI-EcoRV locus. These PAO1 fadD
mutants were confirmed by PCR (data not shown).
These newly engineered mutant strains, PAO1-fadD1::FRT,P A O 1 -
fadD2::FRT,an dP A O1 - DfadD2D1::FRT, werecomplemented using the
relevant gene(s) on the miniCTX2 single copy integration vector as
described previously [56]. The resulting strains, PAO1-fadD1::FRT/
attB::miniCTX2-fadD1, PAO1-fadD2::FRT/attB::miniCTX2-fadD2,
and PAO1-DfadD2D1::FRT/attB::miniCTX2-fadD2D1,w e r eu s e di n
the growth curve experiments (Fig. 4 and 8A). Controls were also
performed with the empty miniCTX2 integrated into each mutant
strain.
Growth characterization of fadD mutant and
complemented strains
The fadD mutants, their corresponding complemented strains,
and the PAO1 wildtype strain were initially grown overnight in
PIB medium. The overnight cultures were centrifuged and the cell
pellets were washed twice with 1x M9 minimal media and
resuspended with equal volumes of the same 1x M9 media. The
cell resuspensions were then diluted 100-fold in 1x M9 +1% Brij-
58 +1% CAA or 0.2% of the individual FAs (C4:0 to C16:0,o r
C18:1
D9; Fig. 4) or 0.2% PC (Fig. 8A), and growth was then
initiated. At each time point, aliquots of individual cultures were
diluted 4-fold in 4% Brij-58 (pre-incubated at 42uC) to clarify any
insoluble FA and OD540 measurements were taken.
Figure 8. Growth analysis on phosphatidylcholine and competition studies. (A) The DfadD2D1 mutant exhibited a growth defect when
grown on PC as a sole carbon source, while the fadD2 mutant had a delayed log phase compared to the wildtype PAO1 strain. The growth defects
were fully recovered in complemented strains, as they had identical growth rates compared to the wildtype PAO1 strain. (B) In vitro competition
studies of the various fadD mutants and their complemented strains in different growth media (n=the number of independent in vitro competition
experiments performed with each carbon source). In vivo lung competition of the various fadD mutants and their complemented strains after 24 h (C)
and 48 h (D). n equals the number of mice in each group that were inoculated with a total of 6610
6 CFU/mouse. The solid red line indicates the
geometric mean of the competitive indices (CI) in each competition group. CI,1 indicates the fadD mutant was less competitive than its
complemented strain in various growth media (B) or within the lungs (C and D) (*, P,0.05 based on one sample t test) [47]. Numbers above the red
line represent the average total recovered CFU/mouse for each competition group.
doi:10.1371/journal.pone.0013557.g008
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and induction by FAs
To take advantage of the native fadD1-promoter and create a
transcriptional fusion of PfadD1-lacZ, pFRT1-lacZ was integrated at
the FRT locus in strain PAO1-fadD1::FRT as previously described
[29]. The resulting fusion strain, PAO1-fadD1::FRT-lacZ, was PCR
confirmed using oligos #341 + #713, which are specific for the
fadD1 and lacZ genes, respectively. Similarly, PAO1-fadD2::FRT-
lacZ was constructed and PCR confirmed using oligos #377 +
#501 (data not shown). Complementation vectors miniCTX2-
fadD1 and miniCTX2-fadD2 were then integrated into these newly
developed lacZ-fusion strains, to yield two complemented fusion
strains, PAO1-fadD1::FRT-lacZ/attB::miniCTX2-fadD1 and PAO1-
fadD2::FRT-lacZ/attB::miniCTX2-fadD2, respectively.
b-Galactosidase activities were measured for these two comple-
mented fusion strains under various growth conditions. Cells were
first grown overnight in PIB medium, washed twice with one
volume of 1x M9, and resuspended in an equal volume of the same
medium. Cell resuspensions were then diluted 100-fold into fresh
1x M9 +1% Brij-58 +1% CAA60.1% of the individual FAs (C4:0
to C16:0,o rC 18:1
D9), and growth curve experiments were
performed. Cell cultures were taken at mid-log phase (OD540
Table 3. Bacterial strains used in this study
a.
Strains Lab ID




- mcrA D(mrr-hsdRMS-mcrBC) Q80dlacZ DM15 DlacX74
deoR recA1 endA1 araD139 D(ara, leu)7697 galU galK rpsL nupG
BioRad
K12 E0577 Prototroph ATCC #23740
K27 E0410 fadD
- (oldD88) mutant [16]
K27-T7 E1063 Gm

















PAO1 P007 prototroph [68]
PAO1-fadD1::FRT P175 PAO1 with fadD1 insertional mutation This study
PAO1-fadD2::FRT P547 PAO1 with fadD2 insertional mutation This study




















































r; fadD2D1 mutant with pUC18 inserted in mucA gene This study
aFor strains constructed in this study, please see text for further details.
bPlease use lab ID for requesting strains.
doi:10.1371/journal.pone.0013557.t003
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Miller Units (mean6s.e.m.) were determined [57] (Fig. 3).
FadD1 and FadD2 purification
Histidine-tagged FadD1 and FadD2 were expressed on the
pET15b vector and purified using a Ni
+-NTA column (Qiagen,
Valencia, CA) as described elsewhere [58]. The E. coli K27-T7
(fadD
-) strain was used for protein expression to prevent any
possible E. coli FadD contamination in protein preparations
(Fig. 5A).
Measurement of fatty acyl-CoA synthetase (FadD1 and
FadD2) activity
Fatty acyl-CoA synthetase activity was monitored using Ell-
man’s reagent, as previously described in several studies, to detect
the amount of free thiol (i.e. CoASH used in the reaction) [23,59–
61]. Reactions (450 ml total) were prepared with 20 mg of purified
FadD1 (or FadD2) in a reaction buffer containing final
concentrations of 150 mM Tris-HCl (pH 7.2), 10 mM MgCl2,
2 mM EDTA, 0.1% Triton X-100, 5 mM ATP, 0.5 mM
coenzyme A (CoASH), and an individual FA (30 to 300 mM) in
thin-walled glass tubes. Briefly, to perform the reaction, each
mixture was assembled containing all components above (exclud-
ing CoASH) and the 405 ml mixture was pre-incubated at 37uC
for 3 min. The reaction was then initiated with the addition of
45 ml of CoASH (5 mM stock in 20 mM Tris-HCl, pH 6.7,
diluted to a final concentration of 0.5 mM) that was pre-incubated
at 37uC for 3 min, quickly mixed, and incubated at 37uC during
the course of the reaction. Immediately after mixing, a time zero
point was taken by removing 75 ml from the 450 ml reaction mix
and adding it to 600 ml of 0.4 mM 5,59-dithiobis(2-nitrobenzoic
acid) (DTNB, dissolved in 0.1 M potassium phosphate at pH 8.0)
and the A412 were measured. Subsequent 75 ml aliquots of the
reaction were taken at 20-sec intervals and mixed with DTNB for
additional measurements. Additionally, control experiments with-
out FadD enzymes were performed exactly as above to show no
change in absorbance at 412 nm and verify the stability of CoASH
and DTNB under these conditions. Reactions with FadD were
repeated to obtain triplicate data for each FA at each
concentration. For each FA substrate, decreases in A412 values
(loss of CoASH) over time were used to calculate the initial velocity
(V0) for each FA concentration (Fig. 5B and 5C). The maximum
velocity (Vmax) of the enzymes and affinity for the different
substrates (Michaelis constant, Km) were then determined using the
Hanes-Woolf plot, rather than the Lineweaver-Burk plot, for
increased accuracy [62]. To determine the Vmax and Km for the
substrate ATP, the same procedure was followed, except that the
concentration of C18:1
D9 was constant (1 mM) and varying
concentrations of ATP (0.05 to 2.5 mM) were used (Table 2).
Motility assays
Strains for swarming and swimming were grown overnight in
LB medium. Cell pellets of 500 ml culture aliquots were washed
twice with equivalent volumes of 1x M9 medium and resuspended
Table 4. Plasmids used in this study
a.
Plasmids Lab ID
b Relevant properties Reference
pEX18T E0055 Ap
r; gene replacement vector [55]
pEX18T-fadD2D1 E0551 Ap












r-FRT-cassette inserted into fadD2D1 This study
pPS856 E0050 Ap
r,G m
r; plasmid with Gm
r-FRT-cassette [55]
pET15b E0047 Ap
r; T7 expression vector Novagen
pET15b-fadD1 E0753 Ap
r; pET15b with fadD1 This study
pET15b-fadD2 E0756 Ap
r; pET15b with fadD2 This study
pET15b-fadDEc E2177 Ap




r-FRT-cassette inserted into fadD2 This study
miniCTX2 E0076 Tet
r; site-specific integration vector [56]
miniCTX2-fadD1 E2157 Tet
r; miniCTX2 with cloned fadD1 This study
miniCTX2-fadD2 E2159 Tet
r; miniCTX2 with cloned fadD2 This study
miniCTX2-fadD2D1 E2143 Tet
r; miniCTX2 with cloned fadD2D1 This study
pUC18 E0135 Ap
r; cloning vector [69]
pUC18-‘mucA’ E1907 Ap
r; mucA internal region cloned into pUC18 This study
pUC19 E0014 Ap
r; cloning vector [69]
pUC19-fadD2D1 E0545 Ap
r; pUC19 with cloned fadD1 and fadD2 This study
pUC19-DfadD2D1::Gm-FRT E0416 Ap
r,G m
r; pUC19-fadD2D1 with a Gm
r-FRT-cassette insertion This study
pFRT1-lacZ-Gm E0790 Gm
r; FRT-lacZ fusion vector [29]
pCD13SK-flp-oriT E0783 Sp
r; suicidal Flp-containing plasmid [29]
pFLP2 E0067 Ap
r; Flp-containing plasmid [55]
aFor plasmids constructed in this study, please see text for further details.
bPlease use lab ID for requesting plasmids.
doi:10.1371/journal.pone.0013557.t004
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assayed by spotting 5 ml of the resuspended cultures onto BM2-
glucose swarm agar plates, made as described previously [63].
Swimming motility was assayed by pin-stabbing 0.3% LB agar
plates with the overnight liquid cultures grown in LB. All
inoculated plates were allowed to dry at room temperature for
10 min, incubated at 37uC for 16 to 18 h, and motility zones were
compared (Fig. 6).
Protease, phospholipase, lipase, and rhamnolipid
detection
Strains were grown in LB medium and cultures were used for
OD540 measurements at various time points (Fig. 7E). For
protease, phospholipase, and lipase assays, clarified supernatant
was obtained at 24 h from 1 ml culture aliquots centrifuged
(16,0006 g) for 2 min at 4uC and filtered through 0.2 mm
hydrophilic PVDF filters (Fisher Scientific). To quantify protease
and phospholipase activities, 4-mm diameter holes were punched
into 2% skim milk NB agar protease plates or blood agar
phospholipase plates (PML Microbiological) and filled twice with
50 ml of each cell-free supernatant, respectively. Both the skim
milk and blood agar plates were incubated at 37uC for 18 h before
analyzing. Similarly, 50 ml of the same cell-free supernatants were
applied five times into 4-mm holes in rhodamine B agar plates
[64], and the plates were imaged using a UV transilluminator after
incubation at 37uC for 3 days to visualize lipase activity. These
plate-based assays were conducted in triplicate and the clearance
zone diameters for skim milk and blood agar plates or the
fluorescent halo diameters for the rhodamine B plates were
measured and compared by percentage conversion relative to the
wildtype PAO1 value and were expressed as an average 6 s.e.m
(Fig. 7A, 7B and 7C).
Rhamnolipid production was assessed using a previously
published methylene blue complexation assay [65]. All strains
were grown for 24 h in LB medium and 1.5 ml of clarified
supernatant for rhamnolipid extraction was obtained from each
culture by room temperature centrifugation (16,0006 g). This
assay was conducted in triplicate and average absorbance was
compared by percentage conversion relative to the wildtype PAO1
value and was expressed as an average 6 s.e.m (Fig. 7D).
Promoter mapping
The transcriptional start sites of the fadD1 and fadD2 genes were
determined as previously described [30]. Briefly, PAO1 was grown
in 1x M9 minimal media supplemented with 0.2% C16:0 to mid-
log phase. This FA was chosen prior to the gene induction studies
and, in retrospect, it was as appropriate as any other FA to map
the fadD promoters. Cells were harvested and total RNA was
isolated to perform cDNA synthesis using a SMART-IIA primer
(#797, Table 5) and the first gene-specific primer (#375 for fadD1
and #372 for fadD2, Table 5). The cDNA was subsequently used
as the template in PCR, using oligos #798 + #376 and #798 +
#373 for fadD1 and fadD2, respectively. Finally, the PCR product
was sequenced using a second nested oligo #377 for fadD1,o r
#374 for fadD2 (Fig. 2).
Northern blot analysis
Wildtype strain, PAO1, was grown in 1x M9 minimal medium
supplemented with 0.2% C8:0,C 14:0,o rC 18:1
D9 as sole carbon
sources. After reaching mid-log phase (OD540,1.0), cells were
harvested at 4uC and total RNA was isolated. Thirty mg of each
RNA sample was used for northern analysis as described
previously [66]. The fadD1 and fadD2 genes were PCR amplified
from pET15b-fadD1 and pET15b-fadD2 using oligos #341 +
#342, and #339 + #340, respectively, and used individually as
probes (Fig. 3A and 3B).
In vitro and in vivo competition studies
Various fadD mutant strains (fadD1, fadD2 and fadD2D1
mutants) and their corresponding complemented strains were
utilized for the in vitro and in vivo competition studies (Table 3). A
mucA insertional mutation was introduced into all strains to
overproduce alginate, as we used a mouse model to allow these
mucoid strains to survive and replicate in the lung as described
previously [52]. Briefly, a 450-bp internal region of the mucA gene
was PCR amplified from PAO1 chromosomal DNA using oligos
#973 and #974 and cloned into the PvuI site of pUC18. The
resultant vector pUC18-‘mucA’ was electroporated into the various
fadD mutant/complemented strains and the mucoid transformants
were selected on PIA plates supplemented with 500 mg/ml
carbenicillin (Cb500). One mucoid colony of each mutant/
complemented strain was then inoculated separately in 3 ml of
PIB + Cb500. After 24 h of incubation in a shaking incubator at
37uC, these cultures were diluted 100 times into 5 ml of fresh PIB
+ Cb500 and grown overnight. Three ml of each overnight culture
was centrifuged (20,0006 g) for 10 min at 4uC and clarified
supernatants were collected. The cell density of each culture was
calculated by plating 10-fold serial dilutions on LB plates. Each
culture was then adjusted to 2610
8 CFU/ml in its own clarified
supernatant, obtained above. At this point, each diluted fadD
mutant strain (fadD1, fadD2 and fadD2D1 mutants) and its
Table 5. Primers used in this study.
















373 – fadD2-race2 59-GAAGTCGAGACTGTCGGGTA-39
374 – fadD2-race1 59-TCGTTCCAGAATTCAGGTTG-39
375 – fadD1-race3
b 59-ACAGGATGTTCGGGTACTG-39
376 – fadD1-race2 59-CGGGATTGATCTCGGCAGCA-39
377 – fadD1-race1 59-GTACTTGTCCTTCCAGAAGT-39
797 – SMART-IIA
b 59-AAGCAGTGGTATCAACGCAGAGTACGCGGG-39
798 – SMART-IIB 59-AAGCAGTGGTATCAACGCAGAGT-39
mucA cloning
937 – mucA-up 59-GAAGCGGATGAACTCGAG-39
938 – mucA-down 59-ACTGACGGCGGATTGTTG-39
aRestriction enzyme sites utilized in this study are underlined.
bPrimers synthesized RNase free and HPLC purified.
doi:10.1371/journal.pone.0013557.t005
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ratio and the resulting mixtures (fadD1/complement, fadD2/
complement, and fadD2D1/complement) were used for inocula-
tion into various growth media (in vitro competition) or mouse
lungs (in vivo competition).
For in vitro competition, each mutant/complement mixture of
equal cell density was diluted 100x into various growth media with
LB, glucose, CAA, PC, C18:1
D9, glycerol, or choline as sole carbon
sources. All cultures were grown at 37uC with shaking for 1–2 days
until the total cell densities reached ,1610
9 CFU/ml. Bacteria
were then quantified by plating dilutions onto LB plates with and
without tetracycline to determine the total number of bacteria
(growth with no tetracycline) and the number of complemented
bacteria (growth with tetracycline). These numbers were used to
determine the in vitro CI (CFUmutant/CFUcomplement when grown
in media) [47]. All experiments were performed in triplicate and
statistical analysis was performed using Graphpad Prism 5.0
software (Fig. 8B).
Male BALB/c mice, 6–8 weeks old, were purchased from
Charles River Laboratories and used in this in vivo competition
study [52]. Before challenge, the mice were anesthetized by the
intraperitoneal injection of 100 mg/kg ketamine and 10 mg/kg
xylazine. Thirty ml of the mutant/complemented strain mixture
(3610
6 CFU of each) was inoculated intratracheally into BALB/c
mice using the BioLITE Intubation System (Braintree Scientific).
After 24 or 48 h, mice were humanely euthanized and lungs were
harvested and homogenized. Bacteria were quantified by plating
dilutions onto growth media with and without tetracycline to
determine the total number of bacteria (growth with no
tetracycline) and the number of complemented bacteria (growth
with tetracycline). These numbers were used to determine the in
vivo CI (CFUmutant/CFUcomplement when grown in mouse lungs)
[47]. A control condition was included using PAO1-mucA::
pUC18/PAO1-mucA::pUC18-miniCTX2 to show that no com-
petitive advantage or disadvantage was conferred by the presence
of the Tet
r marker during in vivo growth (data not shown).
Statistical analysis was performed using Graphpad Prism 5.0
software (Fig. 8C and 8D).
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